PHARMACEUTICAL FORMULATIONS
This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl)...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | hrv ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Dutt, Chaitanya Deshpande, Shailesh Zambad, Shital Kumar Gupta, Ramesh Chandra Latad, Sachin Chaudhari, Anita Kesarwani, Amit Abraham, Jaya Mathur, Anoop Patel, Manish Kotecha, Jignesh Mishra, Vivek |
| description | This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HRP20190783TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HRP20190783TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HRP20190783TT13</originalsourceid><addsrcrecordid>eNrjZJAO8HAM8nV0dg0N8XR29FFw8w_yDfVxDPH09wvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxHkEBRgaGlgbmFsYhIYbGxKkCAP3NIko</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL FORMULATIONS</title><source>esp@cenet</source><creator>Dutt, Chaitanya ; Deshpande, Shailesh ; Zambad, Shital Kumar ; Gupta, Ramesh Chandra ; Latad, Sachin ; Chaudhari, Anita ; Kesarwani, Amit ; Abraham, Jaya ; Mathur, Anoop ; Patel, Manish ; Kotecha, Jignesh ; Mishra, Vivek</creator><creatorcontrib>Dutt, Chaitanya ; Deshpande, Shailesh ; Zambad, Shital Kumar ; Gupta, Ramesh Chandra ; Latad, Sachin ; Chaudhari, Anita ; Kesarwani, Amit ; Abraham, Jaya ; Mathur, Anoop ; Patel, Manish ; Kotecha, Jignesh ; Mishra, Vivek</creatorcontrib><description>This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.</description><language>hrv ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190628&DB=EPODOC&CC=HR&NR=P20190783T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190628&DB=EPODOC&CC=HR&NR=P20190783T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dutt, Chaitanya</creatorcontrib><creatorcontrib>Deshpande, Shailesh</creatorcontrib><creatorcontrib>Zambad, Shital Kumar</creatorcontrib><creatorcontrib>Gupta, Ramesh Chandra</creatorcontrib><creatorcontrib>Latad, Sachin</creatorcontrib><creatorcontrib>Chaudhari, Anita</creatorcontrib><creatorcontrib>Kesarwani, Amit</creatorcontrib><creatorcontrib>Abraham, Jaya</creatorcontrib><creatorcontrib>Mathur, Anoop</creatorcontrib><creatorcontrib>Patel, Manish</creatorcontrib><creatorcontrib>Kotecha, Jignesh</creatorcontrib><creatorcontrib>Mishra, Vivek</creatorcontrib><title>PHARMACEUTICAL FORMULATIONS</title><description>This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAO8HAM8nV0dg0N8XR29FFw8w_yDfVxDPH09wvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxHkEBRgaGlgbmFsYhIYbGxKkCAP3NIko</recordid><startdate>20190628</startdate><enddate>20190628</enddate><creator>Dutt, Chaitanya</creator><creator>Deshpande, Shailesh</creator><creator>Zambad, Shital Kumar</creator><creator>Gupta, Ramesh Chandra</creator><creator>Latad, Sachin</creator><creator>Chaudhari, Anita</creator><creator>Kesarwani, Amit</creator><creator>Abraham, Jaya</creator><creator>Mathur, Anoop</creator><creator>Patel, Manish</creator><creator>Kotecha, Jignesh</creator><creator>Mishra, Vivek</creator><scope>EVB</scope></search><sort><creationdate>20190628</creationdate><title>PHARMACEUTICAL FORMULATIONS</title><author>Dutt, Chaitanya ; Deshpande, Shailesh ; Zambad, Shital Kumar ; Gupta, Ramesh Chandra ; Latad, Sachin ; Chaudhari, Anita ; Kesarwani, Amit ; Abraham, Jaya ; Mathur, Anoop ; Patel, Manish ; Kotecha, Jignesh ; Mishra, Vivek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HRP20190783TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>hrv ; eng</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Dutt, Chaitanya</creatorcontrib><creatorcontrib>Deshpande, Shailesh</creatorcontrib><creatorcontrib>Zambad, Shital Kumar</creatorcontrib><creatorcontrib>Gupta, Ramesh Chandra</creatorcontrib><creatorcontrib>Latad, Sachin</creatorcontrib><creatorcontrib>Chaudhari, Anita</creatorcontrib><creatorcontrib>Kesarwani, Amit</creatorcontrib><creatorcontrib>Abraham, Jaya</creatorcontrib><creatorcontrib>Mathur, Anoop</creatorcontrib><creatorcontrib>Patel, Manish</creatorcontrib><creatorcontrib>Kotecha, Jignesh</creatorcontrib><creatorcontrib>Mishra, Vivek</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dutt, Chaitanya</au><au>Deshpande, Shailesh</au><au>Zambad, Shital Kumar</au><au>Gupta, Ramesh Chandra</au><au>Latad, Sachin</au><au>Chaudhari, Anita</au><au>Kesarwani, Amit</au><au>Abraham, Jaya</au><au>Mathur, Anoop</au><au>Patel, Manish</au><au>Kotecha, Jignesh</au><au>Mishra, Vivek</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL FORMULATIONS</title><date>2019-06-28</date><risdate>2019</risdate><abstract>This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | hrv ; eng |
| recordid | cdi_epo_espacenet_HRP20190783TT1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL FORMULATIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A17%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dutt,%20Chaitanya&rft.date=2019-06-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHRP20190783TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |